Praluent 150 mg/mL

Praluent 150 mg/mL is a subcutaneous injection solution containing alirocumab. It is used to lower cholesterol levels and manage cardiovascular risk. This medication is suitable for adults with certain lipid disorders.

Praluent 150 mg/mL is primarily used to reduce low-density lipoprotein (LDL) cholesterol in adults with primary hyperlipidemia. It is often prescribed for those who do not respond adequately to diet and other cholesterol-lowering treatments. This medication is also used to manage high cholesterol in individuals with heterozygous familial hypercholesterolemia. What is Praluent used for? It helps to lower cholesterol levels and manage cardiovascular risk.

Common effects of Praluent 150 mg/mL may include injection site reactions, such as redness, swelling, or itching. Some individuals may experience flu-like symptoms, including headache, fatigue, or muscle pain. These effects are generally mild and temporary. If you experience persistent or severe symptoms, consult your healthcare provider.

Praluent 150 mg/mL should be stored at room temperature and protected from light. Always use a new syringe for each injection to prevent contamination. Do not share this medication with others, even if they have similar symptoms. Follow your healthcare provider's instructions for proper administration and disposal of the syringe.

Praluent 150 mg/mL may interact with other medications, including cholesterol-lowering drugs and certain antibiotics. Always inform your healthcare provider about all the medications you are taking to avoid potential interactions. Avoid consuming alcohol while using this medication, as it may increase the risk of side effects.